Genomic DNA-Chip Hybridization Reveals a Higher Incidence of Genomic Amplifications in Pancreatic Cancer than Conventional Comparative Genomic Hybridization and Leads to the Identification of Novel Candidate Genes
| Autor: | Swen Wessendorf, Carsten Schwaenen, Karlheinz Holzmann, Peter Lichter, Bettina Rau, Bernd Radlwimmer, Hartmut Döhner, Holger Kohlhammer, Hans A. Kestler, Martin Bentz, Alexandra Schwoerer, Thomas M. Gress |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Male
Cancer Research Candidate gene Chromosomes Human Pair 20 Protein Serine-Threonine Kinases Biology Polymerase Chain Reaction Pancreatic tumor Cell Line Tumor Pancreatic cancer Consensus Sequence medicine Humans Cyclin D1 Gene In Situ Hybridization Fluorescence Aged Oligonucleotide Array Sequence Analysis Aged 80 and over Genetics Chromosomes Human Pair 11 Liver Neoplasms Gene Amplification Nucleic Acid Hybridization Middle Aged MAP Kinase Kinase Kinases BCL6 medicine.disease Molecular biology ErbB Receptors Pancreatic Neoplasms genomic DNA Oncology Trans-Activators Female DNA microarray Comparative genomic hybridization |
| Zdroj: | Cancer Research. 64:4428-4433 |
| ISSN: | 1538-7445 0008-5472 |
| DOI: | 10.1158/0008-5472.can-04-0431 |
| Popis: | Genomic analyses aimed at the detection of high-level DNA amplifications were performed on 13 widely used pancreatic cancer cell lines and 6 pancreatic tumor specimens. For these analyses, array-based comparative genomic hybridization (Matrix-CGH) onto dedicated microarrays was used. In comparison with chromosomal CGH (eight amplifications), a >3-fold number of DNA amplifications was detected (n = 29). The most frequent amplifications mapped to 7p12.3 (three pancreatic cancer cell lines and three pancreatic tumor specimens), 8q24 (four pancreatic cancer cell lines and one pancreatic tumor specimen), 11q13 (three pancreatic cancer cell lines and three pancreatic tumor specimens), and 20q13 (four pancreatic cancer cell lines and three pancreatic tumor specimens). Genes contained in the consensus regions were MYC (8q24), EGFR (7p12.3), and FGF3 (11q13). In six of seven pancreatic cancer cell lines and pancreatic tumor specimens with 20q13 amplifications, the novel candidate gene NFAT C2, which plays a role in the activation of cytokines, was amplified. Other amplifications also affected genes for which a pathogenetic role in pancreatic carcinoma has not been described, such as BCL10 and BCL6, two members of the BCL family. A subset of amplified genes was checked for overexpression by means of real-time PCR, revealing the highest expression levels for BCL6 and BCL10. Thus, Matrix-CGH allows the detection of a high number of amplifications, resulting in the identification of novel candidate genes in pancreatic cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|